These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


140 related items for PubMed ID: 37827008

  • 21. Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.
    Pudlac A, Burgetova A, Dusek P, Nytrova P, Vaneckova M, Horakova D, Krasensky J, Lambert L.
    Biomed Res Int; 2020; 2020():6492786. PubMed ID: 32509866
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW, Park G, Kwak K, Jo HJ, Joung A, Kim JH, Lee SH, Kim S, Lee JM, Kim SH, Kim HJ.
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies.
    Lomer NB, Asalemi KA, Saberi A, Sarlak K.
    PLoS One; 2024 Feb; 19(4):e0300415. PubMed ID: 38626023
    [Abstract] [Full Text] [Related]

  • 28. Analysis of T2 intensity by magnetic resonance imaging of deep gray matter nuclei in multiple sclerosis patients: effect of immunomodulatory therapies.
    Pawate S, Wang L, Song Y, Sriram S.
    J Neuroimaging; 2012 Apr; 22(2):137-44. PubMed ID: 21707826
    [Abstract] [Full Text] [Related]

  • 29. Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R2* - A pilot study in patients with multiple sclerosis and normal controls.
    Taege Y, Hagemeier J, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Schweser F.
    Neuroimage; 2019 Feb 01; 186():308-320. PubMed ID: 30445148
    [Abstract] [Full Text] [Related]

  • 30. Cognitive Implications of Deep Gray Matter Iron in Multiple Sclerosis.
    Fujiwara E, Kmech JA, Cobzas D, Sun H, Seres P, Blevins G, Wilman AH.
    AJNR Am J Neuroradiol; 2017 May 01; 38(5):942-948. PubMed ID: 28232497
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Subcortical brain segmentation of two dimensional T1-weighted data sets with FMRIB's Integrated Registration and Segmentation Tool (FIRST).
    Amann M, Andělová M, Pfister A, Mueller-Lenke N, Traud S, Reinhardt J, Magon S, Bendfeldt K, Kappos L, Radue EW, Stippich C, Sprenger T.
    Neuroimage Clin; 2015 May 01; 7():43-52. PubMed ID: 25610766
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.
    Ceccarelli A, Rocca MA, Perego E, Moiola L, Ghezzi A, Martinelli V, Comi G, Filippi M.
    Mult Scler; 2011 Jun 01; 17(6):702-7. PubMed ID: 21228024
    [Abstract] [Full Text] [Related]

  • 35. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R, Kim G, Tauhid S, Khalid F, Healy BC, Bakshi R.
    PLoS One; 2018 Jun 01; 13(11):e0206939. PubMed ID: 30408094
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Subtyping relapsing-remitting multiple sclerosis using structural MRI.
    Zhuo Z, Li Y, Duan Y, Cao G, Zheng F, Ding J, Tian D, Wang X, Wang J, Zhang X, Li K, Zhou F, Huang M, Li Y, Li H, Zeng C, Zhang N, Sun J, Yu C, Han X, Haller S, Barkhof F, Shi F, Liu Y.
    J Neurol; 2021 May 01; 268(5):1808-1817. PubMed ID: 33387013
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's disease, and elderly healthy controls.
    Jakimovski D, Bergsland N, Dwyer MG, Hagemeier J, Ramasamy DP, Szigeti K, Guttuso T, Lichter D, Hojnacki D, Weinstock-Guttman B, Benedict RHB, Zivadinov R.
    Neurobiol Aging; 2020 Jun 01; 90():84-92. PubMed ID: 32147244
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.